GlassScriptPhysician profile
Amy L Burger
NPI 1790114114
$16,052.40
in general payments reported to CMS, 2019-2025
47 companies · $3,513 in 2025
The $3,513 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,650 · 2022: $2,324 · 2023: $3,092 · 2024: $3,472 · 2025: $3,513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,889 · Education: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,888.59 |
| Education | $188.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,250.68 | 2021-2024 | Axonics |
| Dendreon Pharmaceuticals LLC | $2,126.58 | 2021-2025 | Provenge |
| Astellas Pharma US INC | $1,624.55 | 2021-2025 | Xtandi, Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $1,456.61 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $917.03 | 2021-2025 | Erleada |
| Medtronic, INC. | $912.99 | 2022-2025 | Interstim |
| Pfizer INC. | $705.67 | 2021-2025 | |
| Antares Pharma, INC. | $590.61 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| 180 Medical, INC. | $526.34 | 2021-2025 | Gentlecath, Cure Catheter, Gentlecath Glide |
| Bayer Healthcare Pharmaceuticals INC. | $506.04 | 2021-2025 | |
| Urogen Pharma, INC. | $458.83 | 2021-2025 | Jelmyto |
| Boston Scientific Corporation | $388.68 | 2021-2025 | Ams 700, Axonics, Lithovue |
| Endo USA, INC. | $369.94 | 2024-2025 | Xiaflex, Aveed |
| Abbvie INC. | $294.60 | 2022-2025 | |
| Myovant Sciences INC. | $289.04 | 2021-2022 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $288.78 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Urovant Sciences INC | $249.14 | 2021-2022 | |
| Teleflex LLC | $227.00 | 2021-2023 | Urolift |
| Ferring Pharmaceuticals INC. | $188.14 | 2024-2025 | Adstiladrin |
| Endo Pharmaceuticals INC. | $170.43 | 2021-2024 | Aveed, Xiaflex |
| Novartis Pharmaceuticals Corporation | $150.19 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $117.21 | 2022-2024 | Lynparza |
| Coloplast Corp | $116.94 | 2021-2025 | Speedicath |
| Procept Biorobotics Corporation | $110.20 | 2024-2025 | Aquabeam System |
| Blue Earth Diagnostics | $82.19 | 2021-2023 | |
| Halozyme INC | $77.84 | 2023 | |
| Smith+Nephew, INC. | $68.25 | 2021-2025 | Stravix |
| Sun Pharmaceutical Industries INC. | $67.02 | 2022-2023 | Yonsa |
| Acerus Pharmaceuticals Corporation | $63.74 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $63.17 | 2022-2024 | |
| Tempus Ai, INC | $62.28 | 2025 | Xt Cdx |
| Abc Home Medical Supply, INC. | $61.75 | 2023-2025 | |
| Amgen INC. | $61.37 | 2021 | |
| Azurity Pharmaceuticals, INC. | $54.98 | 2025 | Azmiro |
| Immunitybio, INC. | $47.54 | 2025 | |
| Angiodynamics, INC. | $40.54 | 2022-2024 | Nanoknife |
| Allergan, INC. | $40.16 | 2021 | |
| Telix Pharmaceuticals | $37.32 | 2024-2025 | Illuccix |
| Photocure INC | $34.77 | 2025 | Cysview |
| Hollister Incorporated | $33.19 | 2022-2023 | Onli, Infyna Chic, Vapro |
| Myriad Genetic Laboratories, INC. | $20.41 | 2022 | |
| Olympus America INC. | $18.37 | 2025 | Itind System |
| Provepharm INC. | $18.23 | 2025 | Bludigo |
| Convatec INC. | $18.00 | 2022 | |
| Cardinal Health 414 LLC | $17.87 | 2024 | |
| Laborie Medical Technologies Corp. | $13.99 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.20 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Burger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.